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A B S T R A C T
Since the initial marketing in 2005, the use of e-cigarettes has increased exponentially. Nonetheless, accumu-
lating evidence has demonstrated the ineffectiveness of e-cigarettes in leading to smoking cessation, and de-
creasing the adverse health impacts of cigarette smoking. The number of adolescents adapted to e-cigarettes has
been increasing substantially each year, and this adaptation has promoted openness to tobacco smoking. The
present review discusses controversies regarding the smoking cessation effects of e-cigarettes, recent govern-
mental policies and regulations of e-cigarette use, toxic components and vaporization products of e-cigarettes,
and the novel molecular mechanisms underlying the adverse health impacts of e-cigarettes leading to oxidative
stress in target tissues, and consequent development of cardiopulmonary diseases (i.e. COPD), neurodegenera-
tive disorders (i.e. Alzheimer's’ disease), and cancer. Health warning signs on the packaging and professional
consultation to avoid adaptation in risk groups might be helpful solutions to control negative impacts of e-
cigarettes. It is also recommended to further expand basic and clinical investigations to reveal more detailed
oxidative stress mechanisms of e-cigarette induced damages, which would ultimately result in more effective
protective strategies.
Since the initial marketing in 2005, the use of e-cigarettes has in-
creased exponentially [1]. There are approximately 3 million e-cigar-
ette users in the UK (United Kingdom) [2]. In the USA (United States of
America), the total sales of e-cigarettes are anticipated to exceed to-
bacco products within a decade [3]. It has been shown that more than
half of the current and ex-smokers in the US [4], and 61% of the current
smokers in the UK [2], have tried e-cigarettes. China as the primary
manufacturing center for e-cigarettes (~80%), has the largest smoking
population in the world (3 out of 10 billion), and is rapidly developing
into a nation with the largest population of e-cigarette users [1]. De-
spite being anticipated to help cease smoking, two recent meta-analyses
of clinical trials have indicated that e-cigarettes are not effective in this
regard [5]. Of those studies that showed a significant effect of e-ci-
garettes on smoking cessation, it is unclear whether the reduction in
tobacco smoking was simply a consequence of partial replacement with
e-cigarettes to make the smokers dual users. In addition, the Center for
Disease Control (CDC) reports data showing a dramatic increase in e-
cigarette use in high school students [6], and that this adaptation to e-
cigarettes has been shown to promote openness to tobacco smoking in
adolescents [7]. Among high school students, current e-cigarette use
tripled in a single year – from 660,000 users in 2013 to 2,000,000 in
2014 [8]. It is important to note that the American Thoracic Society and
the American Heart Association cited concerns regarding ineffective-
ness in smoking cessation and potential adverse effects of e-cigarettes in
the 2014 recommendations [9,10], both urging restricted use of e-ci-
garettes until their health impacts are fully understood. It is stated in
both that e-cigarette use may promote nicotine addiction and early
adaptation to e-cigarettes and/or tobacco smoking in teenagers. Im-
portantly, more recent studies have provided evidence that oxidative
stress mediate many of the adverse effects of e-cigarettes.
The e-cigarettes are comprised of three components; a battery
powered heating element, a cartridge (replaceable) or tank (refillable)
containing a solution made of propylene glycol, glycerine, nicotine,
water and flavorings, and an atomizer that vaporizes the solution when
heated (Fig. 1). More than 1000 brands of e-cigarettes and 7764 flavors
of the solution have been produced, with production innovation evol-
ving rapidly [1,8,11]. The market is primarily dominated by small
companies although the large tobacco firms also have product lines.
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The regulatory policies on e-cigarettes have been lacking, at least in
part due to the incompletely understood health impacts of the e-ci-
garettes. With encouragement of the government to promote self-reg-
ulation, the first National Association of Electronic Cigarettes (NAEC)
was established in 2015 in China, which is a professional association
with 1800 industrial participants [1]. Back in 2006, The State Tobacco
Monopoly Administration (STMA) classified e-cigarettes as potentially
harmful chemical products, recommending regulation under the State
Administration of Work Safety [1]. Appropriate regulation is in urgent
need given the potential health hazard induced by e-cigarettes, parti-
cularly considering the e-cigarette marketing to youth and non-smo-
kers. In the UK, e-cigarettes that contain nicotine are regulated either as
tobacco-related products or as licensed medicines [2]. In the US, the
Food and Drug Administration (FDA) established new rules on e-ci-
garette regulations in 2016, with a series of timelines starting in August
2016 (http://fdaregs.info/fda-deeming-regulations/timeline/).
For habitual e-cigarette users or people who use e-cigarettes as a
smoking cessation aid, the chronic use of e-cigarettes, and the use of e-
cigarettes during and after attempted smoking cessation, are associated
with worrisome adverse effects. Most of the e-cigarettes tested for
smoking cessation contain nicotine [9,10], which is known to con-
tribute to cardiopulmonary diseases, neurodegenerative disorders and
cancer [12]. Although consumed at lower levels in e-cigarette users
compared to tobacco cigarette users, this lower level of nicotine has
already passed the threshold of being potentially toxic [13]. For teen-
agers, nicotine exposure will affect brain development and lead to ni-
cotine addiction that has a lifelong impact. Thermal decomposition of
the solvents in e-cigarettes generates an array of organic compounds
including carbonyls, one of which is acrolein (from glycerol/glycerine).
Of note, acrolein has been shown to be capable of inducing COPD [14],
the third leading cause of death worldwide [9]. The levels of acrolein
are elevated in lung fluids of COPD patients [14]. Many of the identified
components released from e-cigarette vaporization are potential carci-
nogens, including toxic metals (cadmium, chromium, lead, manganese
and nickel), acrolein, and other organic compounds such as propylene
oxide formed from propylene glycol [10,15]. The latter, propylene
glycol, is not present in traditional tobacco cigarettes. Direct exposure
of mice to e-cigarette vapors resulted in inflammation and reduced
clearance of bacteria and virus, which are key features of COPD [3]. A
recent study has demonstrated that e-cigarette exposure induced DNA
strand break and apoptosis regardless of nicotine contents [16].
Moreover, some of the flavoring additives have been shown to be pa-
thogenic [8,17]. These flavorings contain cytotoxic [8,17], which are
recognized as “primary irritants” of mucosal tissue of the respiratory
tract [18]. Using gas chromatography/mass spectrometry (GC/MS) to
analyze 28 e-cigarette liquids from seven manufacturers, Hutzler and
colleagues reported that vanillin, ethyl maltol, ethyl vanillin and
menthol were the four most frequently found flavor chemicals, which
were present in 79%, 57%, 50% and 43% of the 28 samples, respec-
tively [19]. Of note, Bahl et al. examined 41 e-cigarette refill fluids for
cytotoxicity to human pulmonary fibroblasts, human embryonic stem
cells and mouse neural stem cells, and noted that when present, the
cytotoxicity was related to the flavor chemicals, especially for cin-
namon-flavored refill fluids [20,21]. The potential pathological effects
of these e-cigarette vaporization products and flavoring additives are
summarized in Fig. 2.
Importantly, the latest studies have demonstrated that the use of e-
cigarettes is associated with increased oxidative stress, which seems to
mediate the adverse effects of e-cigarettes. Oxidative stress develops in
e-cigarette-exposed human bronchial and lung epithelial cells [22,23],
human lung vascular endothelial cells and human umbilical vein en-
dothelial cells [24,25], resulting in inflammation, cytotoxicity and in-
creased endothelial cell permeability [22–26]. In these studies, in-
tracellular production of reactive oxygen species (ROS) was determined
Fig. 1. The making of the e-cigarettes. The e-cigarettes are comprised of three com-
ponents; a battery powered heating element, a cartridge (replaceable) or tank (refillable)
containing a solution made of propylene glycol, glycerine, nicotine, water and flavorings,
and an atomizer that vaporizes the solution when heated.
Fig. 2. Pathological effects induced by e-cigarette compo-
nents and vaporization products. Most of the e-cigarettes used
for smoking cessation contain nicotine, which can be vaporized
by 60–70%. Thermal decomposition of e-cigarette solvents results
in release of toxic metals, and formation of an array of organic
compounds such as acrolein from glycerol, and propylene oxide
from propylene glycol. Frequently used flavoring additives in-
clude vanillin, ethyl matol, ethyl vanillin, and methol. All of these
components and vaporization products have been shown to be
either directly carcinogenic, or toxic in inducing cardiopulmonary
diseases and neurodegenerative disorders.
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using fluorescent probes such as DCF-DA for intracellular hydrogen
peroxide [23,25,27]. Exposure to nicotine that was specifically gener-
ated by the use of e-cigarettes, was shown to promote oxidative stress
dependent impairment of autophagy, which in turn serves as a potential
mechanism leading to development of COPD [27]. Learner and col-
leagues have recently shown that e-cigarette aerosols and copper na-
noparticles induce mitochondrial ROS production, mitochondrial stress
(reduced stability of OxPhos electron transport chain (ETC) complex IV
subunit) and DNA fragmentation in lung fibroblasts [28]. Acrolein has
been shown to provoke oxidative stress and inflammation to result in
loss of endothelial cell barrier integrity in the lung [24]. Propylene
glycol, glycerine, and methanol have all been shown to increase pro-
duction of hydrogen peroxide [28]. The flavoring additive of cinnamon
roll stimulated substantial increase in the production of inflammatory
cytokine IL-8 in human lung fibroblasts [28].
Furthermore, recent reports have confirmed oxidative stress indu-
cing effects of e-cigarettes in animal models in vivo [3,28], and in
human e-cigarette users [10,15]. Electron paramagnetic/spin resonance
(EPR/ESR) determination of free radical production indicated increased
ROS release from e-cigarette vaporization in both cell-free and cell
systems, which is associated with increased lipid peroxidation in the
lung homogenates (assessed by thiobarbituric acid reactive substances
(TBARS)) of e-cigarette exposed mice [3]. The authors also observed a
58% increase in macrophage counts in the bronchoalveolar lavage
(BAL) 24 h after the final exposure (twice per day for two weeks),
which was accompanied by an elevated production of IL-6 [3]. In
healthy human subjects, the use of e-cigarettes stimulated oxidative
stress, nitric oxide deficiency, and endothelial/vascular dysfunction
that translated into impaired flow-mediated dilatation [29]. In addi-
tion, Moheimani et al. recently reported occurrence of oxidative stress
and increased cardiac sympathetic activity in habitual e-cigarette users,
which are known risk factors for cardiovascular diseases [30]. The role
of oxidative stress in mediating adverse effects of e-cigarettes to result
in cardiopulmonary pathogenesis, neurodegenerative disorders and
cancer, is illustrated in Fig. 3.
One may propose that e-cigarette users could take some anti-oxi-
dants to offset the toxicity of oxidative stress. Given the complexities of
how ROS function in vivo for both physiological (low levels of ROS
production are required for growth signaling) and pathological pro-
cesses, and that the detailed molecular mechanisms underlying e-
cigarette induction of oxidative stress have remained unclear, it is not
yet possible to deliver precise anti-oxidative treatments effectively to
control oxidative stress damage. The oxidase systems selectively re-
sponsible for the development of different human diseases are still
under intensive investigations to enable targeted therapies.
Nonetheless, recent studies have demonstrated whereas NADPH oxi-
dase (NOX) isoform 1 (NOX1) is responsible for diabetic vascular
complications [31], NOX4 activation mediates ischemia reperfusion
injury in the heart [32]. Cigarette smoking has been shown to induce
oxidative stress to lead to endothelial dysfunction and vascular diseases
[33–35]. A role of endogenous NOX and extracellular superoxide dis-
mutase (ecSOD) in smoking induced oxidative stress has been im-
plicated [36]. Of note, recent studies indicate that airway smooth
muscle NOX4 can be upregulated to produce ROS in COPD [37].
NOX family oxidases are known to activate other oxidase systems to
result in a vicious cycle of prolonging ROS production, resulting in
sustained oxidative stress and initiation of pathological processes. It
would be important to investigate the oxidase networks to reveal de-
tailed mechanisms of oxidative stress development in response to e-
cigarette exposure. At the present, however, the best solution to prevent
damages caused by e-cigarette-derived oxidative stress might be to
avoid adaptation to e-cigarettes, particularly when their smoking ces-
sation effects are questionable.
Therefore, it is important to give deeper consideration to the
adaptation and regulation of e-cigarettes as an alternative to tobacco
smoking since they introduce new toxic agents, toxicity of which is
poorly understood. With the availability of objective data from human
trials and basic research, appropriate health warnings could be included
on the packaging alerting nicotine-dependent and independent adverse
effects. Recent data indicate that only 22% of e-cigarette liquid bottles
used a warning statement that indicated the product "contained nico-
tine" [38]. None of the statements included the information that nico-
tine was "addictive". Only about half of the websites for e-cigarette
marketing have a minimum age requirement barrier that prevented
under-aged persons from entering [38].
Furthermore, it is probably not too early to start advising the to-
bacco users in the community not to rush into the harmful adaptation of
e-cigarettes, and for physicians to guide populations at risk of relevant
diseases, including cardiopulmonary diseases, neurodegenerative dis-
orders and cancer, to avoid them. These recommended strategies to
Fig. 3. A mediator role of oxidative stress in e-cigarette in-
duced pathogenesis. The toxic components and vaporization
products of e-cigarettes have been shown by recent studies to
induce oxidative stress in human lung and branchial epithelial
cells, and human vascular endothelial cells, resulting in in-
flammation, cytotoxicity and increased endothelial permeability.
It also induces tissue infiltration of activated macrophages.
Impairment in branchial epithelial cell autophagy in response to
e-cigarette derived nicotine, and reduced bacterial and viral
clearance in e-cigarette exposed mouse lung, represent potential
mechanisms leading to development of COPD. Healthy human
subjects responded to e-cigarette exposure with increased oxida-
tive stress, reduced nitric oxide bioavailability, and impaired
endothelial/vascular dysfunction that precede to cardiovascular
diseases.
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better control negative impacts of e-cigarettes are summarized in Fig. 4.
Increasing the awareness of the oxidative stress aspects of the e-cigar-
ette use may prove beneficial in promoting basic and clinical in-
vestigations to further our understandings of the adverse effects of e-
cigarettes to better protect against these detrimental consequences.
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